Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups
Peter Kolchinsky and Raj Shah have another $300 million-plus to play with on the biotech venture side of their investment business.
The two announced Monday morning that they’ve put together their first pure-play venture fund at RA Capital Management, which has been known to bet on just about every angle in healthcare investing — from rounds to follow-on investments at public companies. This new fund of theirs arrives well into a go-go era of new startup financing, with a particular focus on building new biotechs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.